Ubiquitech Software Corp (OTCMKTS:UBQU) reported that its subsidiary HempLife Today™, a growing and innovative firm offering the finest CBD offerings derived from Hemp, recorded outstanding sales on two successive weekends for its CannazALL™ product line of CBD, and the firm projects this upward movement to continue.
Sales of CannazALL™ cannabinoid products witnessed a jump of more than 50% from April 13 to April 18, and a jump of more than 55% in the weekend of April 20 through the 24. The firm mentions numerous reasons for this jump in revenues; A jump of new clients to the CannazALL™ brand via the firms marketing measures, more repeat clients using their Referral and Rebates discounts, a jump in Social Media postings, a growth in the awareness of the CannazALL™ brand and CBD, and, as projected, a strong response to the firms Free-Trial proposal of CannazALL™ CBD GelCaps.
Ubiquitech Software reported that because the Free-Trial offer received extremely positive response, the firm is currently creating a new client acquisition pipeline so that this free offer can be extended over the firms numerous marketing platforms. The firm projects to launch this offer in the imminent weeks and considers this offer will assist it continue to withstand, and substantially increase, its periodical growth.
James Ballas, the CEO, reported that they like to keep Ubiquitech shareholders informed on company’s progress, and the previous two weekends have demonstrated that the marketing plans are paying off. When there is growth of more than 50% then the company certainly know they are moving in the right direction and leading the firm forward correctly. The firm expects to provide shareholders with an update and comprehensive overview on all aspects of the business. Hemp Life was created by a team of highly motivated, health minded and skilled people who know that hemp and related offerings can be a remarkable source of wellbeing in people’s lives.